Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2013

Open Access 01-12-2013 | Research article

Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment

Authors: Adelina Jiménez-Arellanes, Julieta Luna-Herrera, Jorge Cornejo-Garrido, Sonia López-García, María Eugenia Castro-Mussot, Mariana Meckes-Fischer, Dulce Mata-Espinosa, Brenda Marquina, Javier Torres, Rogelio Hernández-Pando

Published in: BMC Complementary Medicine and Therapies | Issue 1/2013

Login to get access

Abstract

Background

New alternatives for the treatment of Tuberculosis (TB) are urgently needed and medicinal plants represent a potential option. Chamaedora tepejilote and Lantana hispida are medicinal plants from Mexico and their hexanic extracts have shown antimycobacterial activity. Bioguided investigation of these extracts showed that the active compounds were ursolic acid (UA) and oleanolic acid (OA).

Methods

The activity of UA and OA against Mycobacterium tuberculosis H37Rv, four monoresistant strains, and two drug-resistant clinical isolates were determined by MABA test. The intracellular activity of UA and OA against M. tuberculosis H37Rv and a MDR clinical isolate were evaluated in a macrophage cell line. Finally, the antitubercular activity of UA and OA was tested in BALB/c mice infected with M. tuberculosis H37Rv or a MDR strain, by determining pulmonary bacilli loads, tissue damage by automated histomorphometry, and expression of IFN-γ, TNF-α, and iNOS by quantitative RT-PCR.

Results

The in vitro assay showed that the UA/OA mixture has synergistic activity. The intracellular activity of these compounds against M. tuberculosis H37Rv and a MDR clinical isolate in a macrophage cell line showed that both compounds, alone and in combination, were active against intracellular mycobacteria even at low doses. Moreover, when both compounds were used to treat BALB/c mice with TB induced by H37Rv or MDR bacilli, a significant reduction of bacterial loads and pneumonia were observed compared to the control. Interestingly, animals treated with UA and OA showed a higher expression of IFN-γ and TNF-α in their lungs, than control animals.

Conclusion

UA and OA showed antimicrobial activity plus an immune-stimulatory effect that permitted the control of experimental pulmonary TB.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koul A, Arnoult E, Lounis N, Guillemont J, Andries K: The challenge of new drug discovery for tuberculosis. Nature. 2011, 469: 483-490.CrossRefPubMed Koul A, Arnoult E, Lounis N, Guillemont J, Andries K: The challenge of new drug discovery for tuberculosis. Nature. 2011, 469: 483-490.CrossRefPubMed
2.
go back to reference Adhvaryu M, Vakharia B: Drug-resistants tuberculosis: emerging treatment options. Clin Pharmacol. 2011, 3: 51-67. doi:10.214/CPAA.S11597PubMedPubMedCentral Adhvaryu M, Vakharia B: Drug-resistants tuberculosis: emerging treatment options. Clin Pharmacol. 2011, 3: 51-67. doi:10.214/CPAA.S11597PubMedPubMedCentral
3.
go back to reference Lenaerts AJ, Degroote MA, Orme IM: Preclinical testing of new drugs for tuberculosis: current challenges. Trends Microbiol. 2008, 16: 48-54.CrossRefPubMed Lenaerts AJ, Degroote MA, Orme IM: Preclinical testing of new drugs for tuberculosis: current challenges. Trends Microbiol. 2008, 16: 48-54.CrossRefPubMed
4.
go back to reference Tomioka H: Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities. Curr Pharm Des. 2006, 2006 (12): 4047-4070.CrossRef Tomioka H: Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities. Curr Pharm Des. 2006, 2006 (12): 4047-4070.CrossRef
5.
go back to reference Aguilar A, Camacho JR, Chino S, Jácquez P, López ME: Herbario Medicinal del IMSS. Informacion Etnobotanica. 1994, Editorial IMSS: México, 1 Aguilar A, Camacho JR, Chino S, Jácquez P, López ME: Herbario Medicinal del IMSS. Informacion Etnobotanica. 1994, Editorial IMSS: México, 1
6.
go back to reference Jimenez A, Meckes M, Alvarez V, Torres J, Parra R: Secondary metabolites from Chamaedora tepejilote (Palmae) are active against Mycobacterium tuberculosis. Phytother Res. 2005, 19: 320-322.CrossRefPubMed Jimenez A, Meckes M, Alvarez V, Torres J, Parra R: Secondary metabolites from Chamaedora tepejilote (Palmae) are active against Mycobacterium tuberculosis. Phytother Res. 2005, 19: 320-322.CrossRefPubMed
7.
go back to reference Jimenez-Arellanes A, Meckes M, Ramirez R, Torres J, Luna-Herrera J: Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases. Phytother Res. 2003, 17: 903-908.CrossRefPubMed Jimenez-Arellanes A, Meckes M, Ramirez R, Torres J, Luna-Herrera J: Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases. Phytother Res. 2003, 17: 903-908.CrossRefPubMed
8.
go back to reference Jimenez-Arellanes A, Meckes M, Torres J, Luna-Herrera J: Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae). J Ethnopharmacol. 2007, 111: 202-205.CrossRefPubMed Jimenez-Arellanes A, Meckes M, Torres J, Luna-Herrera J: Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae). J Ethnopharmacol. 2007, 111: 202-205.CrossRefPubMed
9.
go back to reference Cantrell CL, Franzblau SG, Fischer NH: Antimycobacterial plant terpenoids. Planta Med. 2001, 67: 685-694.CrossRefPubMed Cantrell CL, Franzblau SG, Fischer NH: Antimycobacterial plant terpenoids. Planta Med. 2001, 67: 685-694.CrossRefPubMed
10.
go back to reference Okunade AL, Elvin-Lewis MP, Lewis WH: Natural antimycobacterial metabolites: current status. Phytochemistry. 2004, 65: 1017-1032.CrossRefPubMed Okunade AL, Elvin-Lewis MP, Lewis WH: Natural antimycobacterial metabolites: current status. Phytochemistry. 2004, 65: 1017-1032.CrossRefPubMed
11.
go back to reference Copp BR, Pearce AN: Natural product growth inhibitors of Mycobacterium tuberculosis. Nat Prod Res. 2004, 24: 278-297.CrossRef Copp BR, Pearce AN: Natural product growth inhibitors of Mycobacterium tuberculosis. Nat Prod Res. 2004, 24: 278-297.CrossRef
12.
go back to reference Fontanay S, Grare M, Mayer J, Finance C, Duval RE: Ursolic, oleanolic and betulinic acids: antibacterial spectra and selectivity indexes. J Ethnopharmacol. 2008, 120: 272-276.CrossRefPubMed Fontanay S, Grare M, Mayer J, Finance C, Duval RE: Ursolic, oleanolic and betulinic acids: antibacterial spectra and selectivity indexes. J Ethnopharmacol. 2008, 120: 272-276.CrossRefPubMed
13.
go back to reference Szakiel A, Ruszkowski D, Grudniak A, Kurek A, Wolska KI, Doligalska M, Janiszowska W: Antibacterial and antiparasitic activity of oleanolic acid and its glycosides isolated from marigold (Calendula officinalis). Planta Med. 2008, 74: 1709-1715. doi:10.1055/s-0028-1088315CrossRefPubMed Szakiel A, Ruszkowski D, Grudniak A, Kurek A, Wolska KI, Doligalska M, Janiszowska W: Antibacterial and antiparasitic activity of oleanolic acid and its glycosides isolated from marigold (Calendula officinalis). Planta Med. 2008, 74: 1709-1715. doi:10.1055/s-0028-1088315CrossRefPubMed
14.
go back to reference Kashiwada Y, Wang HK, Nagao T, Kitanaka S, Yasuda I, Fujioka T, Yamagishi T, Cosentino LM, Kozuka M, Okabe H, Ikeshiro Y, Hu CQ, Yeh E, Lee KH: Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids. J Nat Prod. 1998, 61: 1090-1095.CrossRefPubMed Kashiwada Y, Wang HK, Nagao T, Kitanaka S, Yasuda I, Fujioka T, Yamagishi T, Cosentino LM, Kozuka M, Okabe H, Ikeshiro Y, Hu CQ, Yeh E, Lee KH: Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids. J Nat Prod. 1998, 61: 1090-1095.CrossRefPubMed
15.
go back to reference Balanehru S, Nagarajan B: Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem Int. 1991, 24: 981-990.PubMed Balanehru S, Nagarajan B: Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem Int. 1991, 24: 981-990.PubMed
16.
go back to reference Ovesná Z, Vachálková A, Horváthová K, Tóthová D: Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma. 2004, 51: 327-333.PubMed Ovesná Z, Vachálková A, Horváthová K, Tóthová D: Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma. 2004, 51: 327-333.PubMed
17.
go back to reference Saraswat B, Visen PK, Dayal R, Agarwal DP, Patnaik GK: Protective action of ursolic acid against chemical induced hepato-toxicity in rats. Indian J Pharmacol. 1996, 28: 232-239. Saraswat B, Visen PK, Dayal R, Agarwal DP, Patnaik GK: Protective action of ursolic acid against chemical induced hepato-toxicity in rats. Indian J Pharmacol. 1996, 28: 232-239.
18.
go back to reference Rodriguez JA, Astudillo I, Schmeda-Hirschmann G: Oleanolic acid promotes healing of acetic acid-induced chronic gastric lesions in rats. Pharmacol Res. 2003, 48: 291-294.CrossRefPubMed Rodriguez JA, Astudillo I, Schmeda-Hirschmann G: Oleanolic acid promotes healing of acetic acid-induced chronic gastric lesions in rats. Pharmacol Res. 2003, 48: 291-294.CrossRefPubMed
19.
go back to reference You HJ, Choi CY, Kim JY, Park SJ, Hahm KS, Jeong HG: Ursolic acid enhances nitric oxide and tumor necrosis-alpha production via nuclear factor-kappa b activation in the resting macrophages. FEBS Lett. 2001, 509: 156-160.CrossRefPubMed You HJ, Choi CY, Kim JY, Park SJ, Hahm KS, Jeong HG: Ursolic acid enhances nitric oxide and tumor necrosis-alpha production via nuclear factor-kappa b activation in the resting macrophages. FEBS Lett. 2001, 509: 156-160.CrossRefPubMed
20.
go back to reference Choi CY, You HJ, Jeong HG: Nitric oxide and tumor necrosis factor-alfa production by oleanolic acid via nuclear factor kappaB activation in macrophages. Bioch Biophys Res Commun. 2001, 288: 49-55.CrossRef Choi CY, You HJ, Jeong HG: Nitric oxide and tumor necrosis factor-alfa production by oleanolic acid via nuclear factor kappaB activation in macrophages. Bioch Biophys Res Commun. 2001, 288: 49-55.CrossRef
21.
go back to reference Murakami S, Takashima H, Sato-Watanabe M, Chonan S, Yamamoto K, Saitoh M, Saito S, Yoshimura H, Sugawara K, Yang J, Gao N, Zhang X: Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1. FEBS Lett. 2004, 566: 55-59.CrossRefPubMed Murakami S, Takashima H, Sato-Watanabe M, Chonan S, Yamamoto K, Saitoh M, Saito S, Yoshimura H, Sugawara K, Yang J, Gao N, Zhang X: Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1. FEBS Lett. 2004, 566: 55-59.CrossRefPubMed
22.
go back to reference Yoshimura H, Sugawara K, Saito M, Saito S, Murakami S, Miyata N, Kawashima A, Morimoto S, Gao N, Zhang X, Yang J: In vitro TGF-beta1 antagonistic activity of ursolic acid and oleanolic acid isolated from Clerodendranthus spicatus. Planta Med. 2003, 69: 673-675.CrossRefPubMed Yoshimura H, Sugawara K, Saito M, Saito S, Murakami S, Miyata N, Kawashima A, Morimoto S, Gao N, Zhang X, Yang J: In vitro TGF-beta1 antagonistic activity of ursolic acid and oleanolic acid isolated from Clerodendranthus spicatus. Planta Med. 2003, 69: 673-675.CrossRefPubMed
23.
go back to reference Budzikiewicz H, Djerassi C, Williams DH: Structure Elucidation of Natural Products by Mass Spectrometry: Steroids, Terpenoids, Sugars, and Miscellaneous Classes, Volume 2. 1964, USA: Editorial Holden-Day, University of Michigan Budzikiewicz H, Djerassi C, Williams DH: Structure Elucidation of Natural Products by Mass Spectrometry: Steroids, Terpenoids, Sugars, and Miscellaneous Classes, Volume 2. 1964, USA: Editorial Holden-Day, University of Michigan
24.
go back to reference Cheung HT, Williamson DG: NMR signals of methyl groups of triterpenes with oxygen functions at positions 2, 3 and 23. Tetrahedron. 1969, 25: 119-128.CrossRef Cheung HT, Williamson DG: NMR signals of methyl groups of triterpenes with oxygen functions at positions 2, 3 and 23. Tetrahedron. 1969, 25: 119-128.CrossRef
25.
go back to reference Luna-Herrera J, Costa MC, Gonzalez HG, Rodrigues AI, Castilho PC: Synergistic antimycobacterial activities of sesquiterpene lactones from Laurus spp. J Antimicrob Chemoth. 2007, 59: 548-552.CrossRef Luna-Herrera J, Costa MC, Gonzalez HG, Rodrigues AI, Castilho PC: Synergistic antimycobacterial activities of sesquiterpene lactones from Laurus spp. J Antimicrob Chemoth. 2007, 59: 548-552.CrossRef
26.
go back to reference Hernandez-Pando R, Orozco H, Sampieri A, Pavon L, Velasquillo C, Larriva-Sahd J, Alcocer JM, Madrid MV: Correlation between the kinetics of Th1 and Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology. 1996, 89: 26-33.PubMedPubMedCentral Hernandez-Pando R, Orozco H, Sampieri A, Pavon L, Velasquillo C, Larriva-Sahd J, Alcocer JM, Madrid MV: Correlation between the kinetics of Th1 and Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology. 1996, 89: 26-33.PubMedPubMedCentral
27.
28.
go back to reference Bamuamba K, Gammon DW, Meyers P, Dijoux-Franca MG, Scott G: Anti-mycobacterial activity of five plants species used as traditional medicine in the Western Cape province (South Africa). J Ethnopharmacol. 2008, 117: 385-390. doi:10.1016/j.jep.2008.02.007CrossRefPubMed Bamuamba K, Gammon DW, Meyers P, Dijoux-Franca MG, Scott G: Anti-mycobacterial activity of five plants species used as traditional medicine in the Western Cape province (South Africa). J Ethnopharmacol. 2008, 117: 385-390. doi:10.1016/j.jep.2008.02.007CrossRefPubMed
29.
go back to reference Gua JQ, Wang Y, Franzblau SG, Montenegro G, Timmermann BN: Constituents of Quinchamalium majus with potential antitubercular activity. Z Naturforsch C. 2004, 59: 797-802.PubMed Gua JQ, Wang Y, Franzblau SG, Montenegro G, Timmermann BN: Constituents of Quinchamalium majus with potential antitubercular activity. Z Naturforsch C. 2004, 59: 797-802.PubMed
30.
go back to reference Gu JQ, Wang Y, Franzblau SG, Montenegro G, Yang D, Timmermann BN: Antitubercular constituents of Valeriana laxiflora. Planta Med. 2004, 70: 509-514.CrossRefPubMed Gu JQ, Wang Y, Franzblau SG, Montenegro G, Yang D, Timmermann BN: Antitubercular constituents of Valeriana laxiflora. Planta Med. 2004, 70: 509-514.CrossRefPubMed
31.
go back to reference Wächter GA, Valcic S, Flagg ML, Franzblau SG, Montenegro G, Suarez E, Timmermann BN: Antitubercular activity of pentacyclic triterpenoids from plants of Argentina and Chile. Phytomedicine. 1999, 6: 341-345.CrossRefPubMed Wächter GA, Valcic S, Flagg ML, Franzblau SG, Montenegro G, Suarez E, Timmermann BN: Antitubercular activity of pentacyclic triterpenoids from plants of Argentina and Chile. Phytomedicine. 1999, 6: 341-345.CrossRefPubMed
32.
go back to reference Cadwell CG, Franzblau SG, Suarez E, Timmermann BN: Oleanane triterpenes from Junellia tridens. J Nat Prod. 2000, 63: 1611-1614.CrossRef Cadwell CG, Franzblau SG, Suarez E, Timmermann BN: Oleanane triterpenes from Junellia tridens. J Nat Prod. 2000, 63: 1611-1614.CrossRef
33.
go back to reference Somova LO, Nadar A, Rammanan P, Shode FO: Cardiovascular, antihyperlipidemic and anti-oxidant effect of oleanolic and ursolic acids in experimental hypertension. Phytomedicine. 2003, 10: 115-121.CrossRefPubMed Somova LO, Nadar A, Rammanan P, Shode FO: Cardiovascular, antihyperlipidemic and anti-oxidant effect of oleanolic and ursolic acids in experimental hypertension. Phytomedicine. 2003, 10: 115-121.CrossRefPubMed
34.
go back to reference Onwubalili JK, Scott GM, Robinson JA: Deficient immune interferon production in tuberculosis. Clin Exp Immunol. 1985, 59: 405-413.PubMedPubMedCentral Onwubalili JK, Scott GM, Robinson JA: Deficient immune interferon production in tuberculosis. Clin Exp Immunol. 1985, 59: 405-413.PubMedPubMedCentral
35.
go back to reference Rook GA, Hernandez-Pando R: The pathogenesis of tuberculosis. Annu Rev Microbiol. 1996, 50: 259-284.CrossRefPubMed Rook GA, Hernandez-Pando R: The pathogenesis of tuberculosis. Annu Rev Microbiol. 1996, 50: 259-284.CrossRefPubMed
36.
go back to reference Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM: Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993, 178: 2243-2247.CrossRefPubMed Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM: Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993, 178: 2243-2247.CrossRefPubMed
37.
go back to reference Hernandez-Pando R, Orozco H, Arriaga K, Sampieri A, Larriva-Sahd J, Madrid-Marina V: Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-α and transforming growth factor-β, during the course of experimental pulmonary tuberculosis. Immunology. 1997, 90: 607-617.CrossRefPubMedPubMedCentral Hernandez-Pando R, Orozco H, Arriaga K, Sampieri A, Larriva-Sahd J, Madrid-Marina V: Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-α and transforming growth factor-β, during the course of experimental pulmonary tuberculosis. Immunology. 1997, 90: 607-617.CrossRefPubMedPubMedCentral
38.
go back to reference Rangel-Moreno J, Estrada-Garcia I, García-Hernandez ML, Aguilar-Leon D, Marquez R, Hernandez-Pando R: The role of protaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology. 2002, 106: 257-266.CrossRefPubMed Rangel-Moreno J, Estrada-Garcia I, García-Hernandez ML, Aguilar-Leon D, Marquez R, Hernandez-Pando R: The role of protaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology. 2002, 106: 257-266.CrossRefPubMed
39.
go back to reference Fabre RA, Perez TM, Aguilar LD, Rangel MJ, Estrada-Garcia I, Hernandez-Pando R, Estrada PS: Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis. Clin Exp Immunol. 2004, 136: 215-223.CrossRefPubMedPubMedCentral Fabre RA, Perez TM, Aguilar LD, Rangel MJ, Estrada-Garcia I, Hernandez-Pando R, Estrada PS: Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis. Clin Exp Immunol. 2004, 136: 215-223.CrossRefPubMedPubMedCentral
40.
go back to reference Hernandez-Pando R, Aguilar-Leon LD, Orozco H, Serrano A, Ahlem C, Trauger R, Schramm C, Reading C, Frincke J, Rook GA: 16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. J Infect Dis. 2005, 191: 299-306.CrossRefPubMed Hernandez-Pando R, Aguilar-Leon LD, Orozco H, Serrano A, Ahlem C, Trauger R, Schramm C, Reading C, Frincke J, Rook GA: 16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. J Infect Dis. 2005, 191: 299-306.CrossRefPubMed
41.
go back to reference Hernandez-Pando R, Orozco-Esteves H, Maldonado HA, Aguilar-Leon D, Vilchis-Landeros MM, Mata-Espinosa DA, Mendoza V, Lopez-Casillas F: A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis. Clin Exp Immunol. 2006, 144: 264-272.CrossRefPubMedPubMedCentral Hernandez-Pando R, Orozco-Esteves H, Maldonado HA, Aguilar-Leon D, Vilchis-Landeros MM, Mata-Espinosa DA, Mendoza V, Lopez-Casillas F: A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis. Clin Exp Immunol. 2006, 144: 264-272.CrossRefPubMedPubMedCentral
42.
go back to reference Ikeda Y, Murakami A, Fujimora Y, Tachibana H, Yamada K, Masuda D, Hirano K, Yamashita S, Ohigashi H: Aggregated ursolic acid, a natural triterpenoid, induces IL-1beta release from murine peritoneal macrophages: role of CD36. J Immunol. 2007, 178: 4854-4864.CrossRefPubMed Ikeda Y, Murakami A, Fujimora Y, Tachibana H, Yamada K, Masuda D, Hirano K, Yamashita S, Ohigashi H: Aggregated ursolic acid, a natural triterpenoid, induces IL-1beta release from murine peritoneal macrophages: role of CD36. J Immunol. 2007, 178: 4854-4864.CrossRefPubMed
43.
go back to reference Chiang LC, Ng LT, Chiang W, Chang MY, Lin CC: Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides, and phenolic compounds of Plantago species. Planta Med. 2003, 69: 600-604.CrossRefPubMed Chiang LC, Ng LT, Chiang W, Chang MY, Lin CC: Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides, and phenolic compounds of Plantago species. Planta Med. 2003, 69: 600-604.CrossRefPubMed
44.
go back to reference Jung TY, Pham TN, Umeyama A, Shoji N, Hashimoto T, Lee JJ, Takei M: Ursolic acid isolated from Unicaria rhynchophylla activates human dendritic cells via TLR2 and/or TLR4 and induces the production of IFN-gamma by CD4+ naïve T cells. Eur J Pharmacol. 2012, 643: 297-303. doi:10.1016/j.ejphar.2010.06.030CrossRef Jung TY, Pham TN, Umeyama A, Shoji N, Hashimoto T, Lee JJ, Takei M: Ursolic acid isolated from Unicaria rhynchophylla activates human dendritic cells via TLR2 and/or TLR4 and induces the production of IFN-gamma by CD4+ naïve T cells. Eur J Pharmacol. 2012, 643: 297-303. doi:10.1016/j.ejphar.2010.06.030CrossRef
45.
go back to reference Ellner JJ: Review: The immune response in human tuberculosis-implications for tuberculosis control. J Infect Dis. 1997, 176: 1351-1359.CrossRefPubMed Ellner JJ: Review: The immune response in human tuberculosis-implications for tuberculosis control. J Infect Dis. 1997, 176: 1351-1359.CrossRefPubMed
46.
go back to reference Toossi Z, Ellner JJ: The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol. 1998, 87: 107-114.CrossRefPubMed Toossi Z, Ellner JJ: The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol. 1998, 87: 107-114.CrossRefPubMed
47.
go back to reference Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ: Cross-modulation by transforming growth factor beta in human tuberculosis: Suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci USA. 1996, 93: 3193-3198.CrossRefPubMedPubMedCentral Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ: Cross-modulation by transforming growth factor beta in human tuberculosis: Suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci USA. 1996, 93: 3193-3198.CrossRefPubMedPubMedCentral
48.
go back to reference Hirsch CS, Ellner JJ, Blinkhorn R, Toosi Z: In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor β. Proc Natl Acad Sci USA. 1997, 94: 3926-3931.CrossRefPubMedPubMedCentral Hirsch CS, Ellner JJ, Blinkhorn R, Toosi Z: In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor β. Proc Natl Acad Sci USA. 1997, 94: 3926-3931.CrossRefPubMedPubMedCentral
49.
go back to reference Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Ann Rev Immunol. 1998, 16: 137-161.CrossRef Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Ann Rev Immunol. 1998, 16: 137-161.CrossRef
50.
go back to reference van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA: Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med. 1995, 181: 775-779.CrossRefPubMed van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA: Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med. 1995, 181: 775-779.CrossRefPubMed
51.
go back to reference Kuroda E, Sugiura T, Zeki K, Yoshida Y, Yamashita U: Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice. J Immunol. 2000, 164: 2386-2395.CrossRefPubMed Kuroda E, Sugiura T, Zeki K, Yoshida Y, Yamashita U: Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice. J Immunol. 2000, 164: 2386-2395.CrossRefPubMed
52.
go back to reference Schultz RM, Pavlidis NA, Stylos WA, Chirigos MA: Regulation of macrophage tumoricidal function: a role of prostaglandins of the E series. Science. 1978, 202: 320-321.CrossRefPubMed Schultz RM, Pavlidis NA, Stylos WA, Chirigos MA: Regulation of macrophage tumoricidal function: a role of prostaglandins of the E series. Science. 1978, 202: 320-321.CrossRefPubMed
53.
go back to reference Renz H, Gong JH, Schmidt A, Nain M, Gemsa D: Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol. 1988, 141: 2388-2393.PubMed Renz H, Gong JH, Schmidt A, Nain M, Gemsa D: Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol. 1988, 141: 2388-2393.PubMed
54.
go back to reference Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ: Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res. 2000, 60: 2399-2404.PubMed Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ: Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res. 2000, 60: 2399-2404.PubMed
55.
go back to reference Dharmappa KK, Kumar RV, Nataraju A, Mohamed R, Shivaprasad HV, Vishwanath BS: Anti-inflammatory effect of oleanolic acid by inhibition of secretory phospholipase A2. Planta Med. 2009, 75: 211-215.CrossRefPubMed Dharmappa KK, Kumar RV, Nataraju A, Mohamed R, Shivaprasad HV, Vishwanath BS: Anti-inflammatory effect of oleanolic acid by inhibition of secretory phospholipase A2. Planta Med. 2009, 75: 211-215.CrossRefPubMed
56.
go back to reference Nataraju A, Raghavendra Gowda CD, Rajesh R, Vishwanath BS: Group IIA secretory PLA2 inhibition by ursolic acid; a potent anti-inflammatory molecule. Curr Top Med Chem. 2007, 7: 801-809.CrossRefPubMed Nataraju A, Raghavendra Gowda CD, Rajesh R, Vishwanath BS: Group IIA secretory PLA2 inhibition by ursolic acid; a potent anti-inflammatory molecule. Curr Top Med Chem. 2007, 7: 801-809.CrossRefPubMed
57.
go back to reference Ikeda Y, Murakami A, Ohigashi H: Strain differences regarding susceptibility to ursolic acid-induced interleukin-1beta release in murine macrophages. Life Sci. 2008, 83: 43-49.CrossRefPubMed Ikeda Y, Murakami A, Ohigashi H: Strain differences regarding susceptibility to ursolic acid-induced interleukin-1beta release in murine macrophages. Life Sci. 2008, 83: 43-49.CrossRefPubMed
58.
go back to reference Ikeda Y, Murakami A, Ohigashi H: Ursolic acid: an anti and pro-inflammatory triterpenoids. Mol Nutr Food Res. 2008, 52: 26-42.CrossRefPubMed Ikeda Y, Murakami A, Ohigashi H: Ursolic acid: an anti and pro-inflammatory triterpenoids. Mol Nutr Food Res. 2008, 52: 26-42.CrossRefPubMed
59.
go back to reference Cornejo-Garrido J, Chamorro-Cevallos G, Garduño-Siciliano L, Hernández-Pando R, Jimenez-Arellanes MA: Acute and subacute toxicity (28 days) of a mixture of ursolic acid and oleanolic acid obtained from Bouvardia ternifolia in mice. Bol Latinoam Caribe Plantas Med Aromat. 2012, 11: 91-102. Cornejo-Garrido J, Chamorro-Cevallos G, Garduño-Siciliano L, Hernández-Pando R, Jimenez-Arellanes MA: Acute and subacute toxicity (28 days) of a mixture of ursolic acid and oleanolic acid obtained from Bouvardia ternifolia in mice. Bol Latinoam Caribe Plantas Med Aromat. 2012, 11: 91-102.
Metadata
Title
Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment
Authors
Adelina Jiménez-Arellanes
Julieta Luna-Herrera
Jorge Cornejo-Garrido
Sonia López-García
María Eugenia Castro-Mussot
Mariana Meckes-Fischer
Dulce Mata-Espinosa
Brenda Marquina
Javier Torres
Rogelio Hernández-Pando
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2013
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-13-258

Other articles of this Issue 1/2013

BMC Complementary Medicine and Therapies 1/2013 Go to the issue